- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 100 Years
- Sexes
- All
Research at a glance
Top areas of exploration
- Mycobacterium tuberculosis , 21 publications
- Antitubercular Agents , 20 publications
- COVID-19 , 18 publications
- Tuberculosis, Pulmonary , 15 publications
Research activity
Active clinical trials
- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 100 Years
- Sexes
- All
- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 100 Years
- Sexes
- All
My publications
Filter publications
235 publications
2023
Predicting COVID-19 cases using SARS-CoV-2 RNA in air, surface swab and wastewater samples.
The Science of the total environment
PubMed • Publisher's site2023
Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis.
Pulmonary therapy
PubMed • Publisher's site2023
Role of anti-tumor necrosis factor-alpha agents in treatment of sarcoidosis: A meta-analysis
European Journal of Internal Medicine
Publisher's site2023
Sarcoidosis-associated pulmonary fibrosis: joining the dots.
European respiratory review : an official journal of the European Respiratory Society
PubMed • Publisher's site2022
Anti-inflammatory Properties of the Alpha-Melanocyte-Stimulating Hormone in Models of Granulomatous Inflammation.
Lung
PubMed • Publisher's site